Next Article in Journal
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
Next Article in Special Issue
Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer
Previous Article in Journal
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
Previous Article in Special Issue
Current Pathology Model of Pancreatic Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(18), 4409; https://doi.org/10.3390/cancers14184409
Action Date Notes Link
article xml file uploaded 11 September 2022 08:13 CEST Original file -
article xml uploaded. 11 September 2022 08:13 CEST Update -
article pdf uploaded. 11 September 2022 08:13 CEST Version of Record https://www.mdpi.com/2072-6694/14/18/4409/pdf-vor
article supplementary file uploaded. 11 September 2022 08:13 CEST - https://www.mdpi.com/2072-6694/14/18/4409#supplementary
article html file updated 11 September 2022 08:15 CEST Original file -
article xml file uploaded 14 September 2022 03:49 CEST Update -
article xml uploaded. 14 September 2022 03:49 CEST Update -
article pdf uploaded. 14 September 2022 03:49 CEST Updated version of record https://www.mdpi.com/2072-6694/14/18/4409/pdf-vor
article html file updated 14 September 2022 03:50 CEST Update -
article xml file uploaded 22 September 2022 04:09 CEST Update -
article xml uploaded. 22 September 2022 04:09 CEST Update https://www.mdpi.com/2072-6694/14/18/4409/xml
article pdf uploaded. 22 September 2022 04:10 CEST Updated version of record https://www.mdpi.com/2072-6694/14/18/4409/pdf
article html file updated 22 September 2022 04:11 CEST Update -
article html file updated 28 February 2023 13:11 CET Update https://www.mdpi.com/2072-6694/14/18/4409/html
Back to TopTop